Could Naringenin Participate as a Regulator of Obesity and Satiety?

• Published in: Molecules (Basel, Switzerland) Vol. 28; no. 3; p. 1450
• Main Authors: López-Almada, Gabriela, Domínguez-Avila, J. Abraham, Mejía-León, María Esther, Robles-Sánchez, Maribel, González-Aguilar, Gustavo A., Salazar-López, Norma Julieta
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 02.02.2023; MDPI
• Subjects: Antioxidants; Body fat; Body mass index; Cardiovascular diseases; Cholecystokinin; Citrus; Citrus fruits; Diabetes Mellitus, Type 2 - complications; dyslipidemia; enterohormones; Enzymes; Fatty liver; Flavanones - pharmacology; Flavonoids; Free radicals; Fruits; Gene expression; Humans; Inflammation; Inflammation - complications; Inflammation - drug therapy; Insulin Resistance; Leptin; Lipids; Liver; Liver diseases; Metabolic disorders; Metabolites; naringenin; Non-alcoholic Fatty Liver Disease - complications; Obesity; Obesity - metabolism; Overweight; phenolic compounds; Prevention; Review; satiety; Small intestine; Type 2 diabetes; Weight control; Mexico; naringenin; phenolic compounds; satiety; dyslipidemia; overweight; enterohormones
• ISSN: 1420-3049; 1420-3049
• DOI: 10.3390/molecules28031450

Obesity is a serious health problem worldwide, since it is associated with multiple metabolic disorders and complications such as cardiovascular disease, type 2 diabetes, fatty liver disease and overall metabolic dysfunction. Dysregulation of the hunger–satiety pathway, which includes alterations of central and peripheral signaling, explains some forms of obesity by favoring hyperphagia and weight gain. The present work comprehensively summarizes the mechanisms by which naringenin (NAR), a predominant flavanone in citrus fruits, could modulate the main pathways associated with the development of obesity and some of its comorbidities, such as oxidative stress (OS), inflammation, insulin resistance (IR) and dyslipidemia, as well as the role of NAR in modulating the secretion of enterohormones of the satiety pathway and its possible antiobesogenic effect. The results of multiple in vitro and in vivo studies have shown that NAR has various potentially modulatory biological effects against obesity by countering IR, inflammation, OS, macrophage infiltration, dyslipidemia, hepatic steatosis, and adipose deposition. Likewise, NAR is capable of modulating peptides or peripheral hormones directly associated with the hunger–satiety pathway, such as ghrelin, cholecystokinin, insulin, adiponectin and leptin. The evidence supports the use of NAR as a promising alternative to prevent overweight and obesity.